Literature DB >> 8772554

A direct relationship between thyroid enlargement and breast cancer.

P P Smyth1, D F Smith, E W McDermott, M J Murray, J G Geraghty, N J O'Higgins.   

Abstract

Despite extensive study, evidence to support a direct relationship between diseases of the thyroid and breast has not been established. In this study thyroid volume was assessed by ultrasound in 200 patients with breast cancer and 354 with benign breast disease. Results were compared to appropriate female control groups. Both mean thyroid volume (21.1 +/- 1.4 mL) and the percentage of individual patients with enlarged (> 18.0 mL) thyroid glands (41.5%) were significantly greater in the breast cancer group than equivalent values (13.2 +/- 0.5 mL and 10.5%, respectively) in age-matched controls (P < 0.01 in both cases). The mean thyroid volume of 14.5 +/- 0.34 mL in patients with benign breast disease was also significantly greater than that of 12.5 +/- 0.38 mL in younger controls (P < 0.01). The results support a direct association between breast cancer and increased thyroid volume as mean thyroid volumes and the percentage of individual patients with enlarged thyroid glands were similar in those studied both before (20.8 +/- 1.3 mL and 43.0%) and after (21.4 +/- 1.6 mL and 40.0%) therapies for breast cancer. Although there is no evidence that thyroid enlargement represents a risk factor for breast cancer, the results emphasize the importance of raising the consciousness of the coincidence of both disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772554     DOI: 10.1210/jcem.81.3.8772554

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Hypothalamus-pituitary-thyroid axis disruption in rats with breast cancer is related to an altered endogenous oxytocin/insulin-regulated aminopeptidase (IRAP) system.

Authors:  María Pilar Carrera-González; María Jesús Ramírez-Expósito; Jose Manuel Arias de Saavedra; Rafael Sánchez-Agesta; María Dolores Mayas; Jose Manuel Martínez-Martos
Journal:  Tumour Biol       Date:  2011-01-05

Review 2.  Triiodothyronine and breast cancer.

Authors:  Maria Teresa De Sibio; Miriane de Oliveira; Fernanda Cristina Fontes Moretto; Regiane Marques Castro Olimpio; Sandro José Conde; Aline Carbonera Luvizon; Célia Regina Nogueira
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  Breast Cancer Risk in Postmenopausal Women with Medical History of Thyroid Disorder in the Women's Health Initiative.

Authors:  Chien-Hsiang Weng; Erin R Okawa; Mary B Roberts; Sue K Park; Christopher B Umbricht; JoAnn E Manson; Charles B Eaton
Journal:  Thyroid       Date:  2020-02-03       Impact factor: 6.568

4.  Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor?

Authors:  Kathleen M Kokolus; Chi-Chen Hong; Elizabeth A Repasky
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

5.  Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CHO cells.

Authors:  P Fierabracci; A Pinchera; M Tonacchera; P Agretti; G De Marco; S Albertini; G Conforti; E Seregni; R Agresti; L Grasso; C Giani
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

Review 6.  Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis.

Authors:  Y Fang; L Yao; J Sun; R Yang; Y Chen; J Tian; K Yang; L Tian
Journal:  J Endocrinol Invest       Date:  2017-05-17       Impact factor: 4.256

7.  The relationship between expression of the sodium/iodide symporter gene and the status of hormonal receptors in human breast cancer tissue.

Authors:  Hyun Jung Oh; June-Key Chung; Joo Hyun Kang; Won Jun Kang; Dong Young Noh; In Ae Park; Jae Min Jeong; Dong Soo Lee; Myung Chul Lee
Journal:  Cancer Res Treat       Date:  2005-08-31       Impact factor: 4.679

8.  Serum anti - TPO levels in benign and malignant breast tumors.

Authors:  Shruti Mohanty; Pragna Rao
Journal:  Indian J Clin Biochem       Date:  2009-09-16

9.  Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women.

Authors:  Ada Tosovic; Anne-Greth Bondeson; Lennart Bondeson; Ulla-Britt Ericsson; Johan Malm; Jonas Manjer
Journal:  Breast Cancer Res       Date:  2010-06-11       Impact factor: 6.466

Review 10.  The thyroid, iodine and breast cancer.

Authors:  Peter P A Smyth
Journal:  Breast Cancer Res       Date:  2003-07-29       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.